Method of vagal stimulation to treat patients suffering from congestive heart failure

• US 20110087304A1
• Filed: 09/10/2010
• Published: 04/14/2011
• Est. Priority Date: 10/01/2001
• Status: Active Grant

• Current Assignee: Maik Gollasch
• Original Assignee: Maik Gollasch
• Inventors: Gollasch, Maik
• Granted Patent: US 8,457,743 B2
• Time in Patent Office: Days
• US Class Current: 607/18
• CPC Class Codes: A61B 2562/0219 Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
• CPC Class Codes: A61B 5/0031 Implanted circuitry
• CPC Class Codes: A61B 5/0537 Measuring body composition by impedance, e.g. tissue hydration or fat content
• CPC Class Codes: A61B 5/0809 by impedance pneumography
• CPC Class Codes: A61B 5/316 Modalities, i.e. specific diagnostic methods
• CPC Class Codes: A61N 1/36114 Cardiac control, e.g. by vagal stimulation stimulating the heart A61N1/362
• CPC Class Codes: A61N 1/36139 with automatic adjustment
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: A61N 1/36521 the parameter being derived from measurement of an electrical impedance

Abstract

An improved method is presented for evaluating the physiological status of a patient diagnosed with congestive heart failure and treating the patient accordingly to alleviate the congestive heart failure. As part of the method, the thoracic or cardiac impedance and ventilation of the particular patient are derived solely from an input consisting of cardiac signals (EKG) generated by electrical energy of the patient'"'"'s heart as the heart is undergoing its cardiac cycle with a dynamic impedance obtained by subjecting the EKG to alternately high and low input impedances. The derived thoracic impedance and ventilation are used to control the pattern and rate at which stimulating electrical pulses are applied to the patient'"'"'s vagus nerve by an implanted stimulator, in a manner to deliver therapy to the patient'"'"'s heart by adjusting the heart rate to a prescribed target rate for alleviating the congestive heart failure. A change in state of the patient from one of rest to one of physical exercise and vice versa detected from the derived impedance and ventilation is accommodated by modifying the vagal stimulation therapy to adjust the patient'"'"'s heart rate to a new target rate accordingly, while continuing to deliver the therapy for alleviating the congestive heart failure. A closed loop system is preferably employed for the control and adjustment functions.

Claims

1. A method of evaluating the cardio-circulatory and ventilatory condition of a human patient suffering from congestive heart failure disorder for delivery of therapy to alleviate the disorder, which comprises the steps of:

sensing cardiac signals emanating from electrical energy generated by the patient'"'"'s heart as the heart undergoes its cardiac cycle,

applying the sensed electrical signals with a dynamic impedance as the sole input to signal detection circuitry to determine the patient'"'"'s thoracic impedance and ventilation therefrom, and

stimulating the patient'"'"'s vagus nerve with stimulation pulses in a pattern and at a rate controlled by the determined impedance and ventilation.

2. The method of claim 1, including:

applying said stimulation pulses to the vagus nerve at a site in the patient'"'"'s neck.

3. The method of claim 1, including:

applying said stimulation pulses at a site above a cardiac branch of the vagus nerve.

4. The method of claim 1, including:

applying said stimulation pulses at a site where a cardiac branch departs from the main branch of the vagus nerve.

5. The method of claim 1, including:

performing said sensing of cardiac signals utilizing at least in part electrode means used for said stimulating of the vagus nerve.

6. The method of claim 1, including:

sensing a state of physical activity of the patient from said impedance and ventilation determination, and

adjusting the pattern and rate of said stimulation pulses to control the heart rate of said patient according to said sensed state of physical activity as a part of said therapy.

7. The method of claim 6, including:

sensing the intensity of physical activity in said sensed state from said impedance and ventilation determination, and

performing said adjusting of the pattern and rate of said stimulation pulses to control the heart rate of said patient according to said intensity of physical activity, not exceeding a predetermined level of heart rate prescribed as safe for said patient, as a part of said therapy.

8. The method of claim 1, including:

providing said sensed electrical signals with dynamic impedance by subjecting said sensed electrical signals to alternately high and low input impedances prior to said application as said sole input to signal detection circuitry.

9. A method of delivering therapy to a patient suffering from chronic heart failure, said method comprising the steps of:

applying vagal stimulation to the patient to provide a therapeutic heart rate for said patient,

controlling the pattern, timing and frequency of said vagal stimulation according to thoracic impedance and ventilation of the patient, whereby to provide said therapeutic heart rate, and

deriving said thoracic impedance and ventilation solely from EKG signals produced by electrical energy generated by the patient'"'"'s heart with intervening dynamic impedance.

10. The method of claim 9, including:

applying said vagal stimulation by delivering electrical pulses having said pattern, timing and frequency to the patient'"'"'s vagus nerve at a cervical location at or above the site at which a cardiac branch divides from the main branch of the vagus nerve.

11. The method of claim 9, including:

sensing said EKG signals via electrode means engaging the patient'"'"'s vagus nerve from which to derive said thoracic impedance and ventilation.

12. The method of claim 11, including:

performing said sensing of cardiac signals utilizing at least in part electrode means used for said stimulating of the vagus nerve.

13. The method of claim 12, including:

utilizing neurostimulator means implanted in said patient for applying said vagal stimulation, said neurostimulator means including a case and a header on said case for operatively coupling said electrode means used for stimulating to said neurostimulator means, and

performing said sensing of cardiac signals utilizing at least one additional electrode means among electrode means on said case, on said header, or on said vagus nerve, in combination with said electrode means used for said stimulating of the vagus nerve.

14. The method of claim 9, including:

detecting a state of physical activity of the patient from said derived impedance and ventilation, and

adjusting the pattern, timing and frequency of the vagal stimulation to provide a therapeutic heart rate reflecting said detected state of physical activity.

15. The method of claim 14, including:

detecting the level of said physical activity from said derived impedance and ventilation, and

performing an adjustment of said pattern, timing and frequency of vagal stimulation to provide a therapeutic heart rate reflecting said detected level of physical activity, limited to a maximum heart rate deemed to be safely tolerated by said patient, as a part of said therapy.

16. The method of claim 9, including:

providing said EKG signals with said intervening dynamic impedance by subjecting said EKG signals to an alternating high input impedance and low input impedance prior to deriving said thoracic impedance and ventilation.

17. A method of evaluating the status of congestion of a patient diagnosed with congestive heart failure and applying vagal stimulation therapy to alleviate the congestive heart failure, said method comprising the steps of:

deriving the patient'"'"'s thoracic impedance and ventilation solely by processing cardiac signals generated by electrical energy of the patient'"'"'s heart as the heart is undergoing its cardiac cycle while subjecting said cardiac signals to a dynamic input impedance, to assess said status of congestion, and

controlling the pattern and frequency of said applied vagal stimulation therapy according to the derived impedance and ventilation to adjust the patient'"'"'s heart rate to a prescribed therapeutic rate.

18. The method of claim 17, including

applying said vagal stimulation therapy to the patient'"'"'s vagus nerve at a site at or above the branching of a cardiac branch from the main branch of the patient'"'"'s vagus nerve.

19. The method of claim 17, including:

detecting a change in state of the patient from one of rest to one of physical exercise and vice versa from said derived impedance and ventilation, and

adjusting said vagal stimulation therapy for control of the patient'"'"'s heart rate to a target rate that accommodates said change in state while delivering said therapy.

20. The method of claim 19, including:

detecting intensity of said physical exercise from said derived impedance and ventilation, and

further adjusting said vagal stimulation therapy to a new said target heart rate to reflect the detected intensity of physical exercise, while maintaining said new target rate within a prescribed safe maximum rate.

21. The method of claim 17, including:

using a closed loop system to control said pattern and frequency of applied vagal stimulation therapy, and thereby to adjust the patient'"'"'s target heart rate to at least partly reflect a feedback signal.

22. The method of claim 17, including:

subjecting said cardiac signals to dynamic input impedance by placing alternately high and low input impedances in the path of said cardiac signals as a part of the processing to derive patient thoracic impedance and ventilation.